IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION
Registration now open!
MM2025 Pre-conference sessions will be held on Thursday 27 November.
Early bird registration for all pre-conference sessions closes at 11:59pm AEST Thursday 2 October 2025.
Registration is required for all pre-conference sessions. All registration rates are listed in AUD and inclusive of GST.
This interactive workshop has been designed to validate and align key concepts across policy, technology, and clinical practice, supporting the transformation of hospital medication management, with a focus on electronic medication chart prescriptions, including those generated on discharge and in outpatient clinics.
Participants will receive key updates on the National Electronic Medication Chart Framework (NEMCF) and will contribute to validating and exploring how upcoming changes to the national electronic chart requirements, Electronic Prescribing Conformance Profiles, and Solution Architecture concepts will support the implementation of national electronic medication charts.
The collaborative workshop will encourage participants to consider the potential impact on current workflows, particularly during transitions of care and community pharmacy interactions, to identify potential implications for health services, and to share valuable hospital insights.
Feedback will play a crucial role in shaping future policies and technical requirements, ensuring that the introduction of national electronic medication charts and electronic prescribing in hospitals is practical, well-integrated, and supports clinical workflows in hospital settings.
Additionally, participants will receive updates on broader policy initiatives, including the Electronic Prescribing by Default project (formerly the Electronic Prescribing Mandate project) and the electronic sharing of medicines information.
Time: 1100-1600 AEDT
Room: 220
Facilitators:
Program
| Time (AEDT) | Topic |
| 1030-1100 | ARRIVAL TEA & COFFEE |
| 1100-1115 | Welcome, introductions and housekeeping Vicki Ibrahim, Director Medicines Safety Program, ADHA |
| 1115-1130 | Electronic prescribing by default update Informational session Jessica Chambers, Director Medicines Policy and Digital Integration Section, DHDA |
| 1130-1230 | National Electronic Medication Chart Framework (NEMCF) overview and impact analysis discussion Informational and interactive session Jenene Baker, Director Medicines Management and Safety Section, DHDA |
| 1230-1300 | LUNCH |
| 1300-1500 | Validation of proposed new electronic prescribing solution architecture concepts Informational and interactive session Medicines Safety Program & Conformance and Assurance, ADHA |
| 1500-1515 | AFTERNOON TEA |
| 1515-1615 | Future eLearning module for electronic prescribing implementation Interactice session Medicines Safety Program, ADHA |
| 1615-1630 | Reflection, wrap-up and next steps Vicki Ibrahim, Director Medicines Safety Program, ADHA |
Registration information
Registration includes tea and coffee on arrival, lunch, and afternoon tea
| Registration category | Standard |
|---|---|
| AdPha member | FREE |
| Non-member | FREE |
Time: 1030am-1230pm AEDT
Room: 219
Facilitators:
Program
| Time (AEDT) | Topic |
| 1000-1030 | ARRIVAL TEA AND COFFEE |
| 1030-1050 | Welcome and housekeeping Overview of ANZCAP and the three levels of ANZCAP Pharmacist recognition Presentation |
| 1050-1100 | Introductions Small group session: Icebreaker & reflection on own practice |
| 1100-1120 | Introduction to Learning Experiences (LXs) Presentation |
| 1120-1145 | Document a Learning Experience (LX) Small group session: Access ANZCAP, start to document your own LXs and discuss how your practice aligns with each LX |
| 1145-1200 | Introduction to ANZCAP portfolios Presentation |
| 1200-1215 | Core Learning Experiences Small group session: determine how your practice aligns with core LX requirements in the Resident, Registrar or Consultant recognition portfolio |
| 1215-1230 | Questions and close |
Registration information
Registration includes an arrival snack.
| Registration category | Early bird | Standard |
|---|---|---|
| AdPha member | FREE | FREE |
| Non-member | $50 | $70 |
Accreditation
This activity has been accredited for 1 hour of Group-1 CPD and 1 hour of Group-2 CPD for a total of 3 CPD credits, suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number for your reference is S2025/68.
Gain invaluable insights into leadership from renowned speakers from the University of North Carolina (UNC) at Chapel Hill, USA.
The team from UNC Chapel Hill has delivered this training to Victorian Hospital Pharmacy Directors for many years and we are now making it available to you!
Presented by Associate Professor Kathryn Morbitzer and Assistant Professor Michael Stepanovic from UNC Chapel Hill’s School of Pharmacy, ranked #1 in the US and #7 in the QS World Rankings for Pharmacy and Pharmacology (2024). Join us as they share their insights, strategies and vision for leadership.
Time: 0930-1600 AEDT
Room: 207
Facilitators:
Preliminary program
| Time (AEDT) | Topic |
| 0930-1000 | ARRIVAL MORNING TEA |
| 1000-1005 | Welcome |
| 1005-1010 | Introduction |
| 1010-1140 | Session 1: Leadership: The essential ingredient |
| 1140-1240 | Session 2: Inspire a shared vision: Strategic planning |
| 1240-1330 | LUNCH |
| 1330-1500 | Session 3: Using data to tell your story |
| 1500-1515 | AFTERNOON TEA |
| 1515-1645 | Session 4: The business plan: Roadmap to the future |
| 1645-1700 | Thank you and close |
Registration information
Registration includes morning tea, lunch and afternoon tea.
| Registration category | Early bird | Standard |
|---|---|---|
| AdPha member | $345 | $395 |
| Non-member | $395 | $445 |
Accreditation
This activity has been accredited for 5.5hrs of Group 2 CPD (or 11 CPD credits), suitable for inclusion in an individual pharmacist's CPD plan. The accreditation number is S2025/30.
Led by the AdPha Medication Safety Leadership Committee
Time: 1330-1700 AEDT
Room: 219
Program
| Time (AEDT) | Topic & presenters |
| 1330-1340 | Introductions and housekeeping Presentation Toni Howell, Senior Pharmacist (Medication Safety and Strategy), St Vincent's Hospital Melbourne, Melbourne, Vic |
| 1340-1350 | Getting your medication safety message across in “Two minutes on Tuesday” Presentation Toni Howell, Senior Pharmacist (Medication Safety and Strategy), St Vincent's Hospital Melbourne, Melbourne, Vic |
| 1350-1420 | Theories of behaviour change: what drives change in individuals Presentation Dr Justin Turner, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic |
| 1420-1450 | How to increase public awareness and engagement Presentation Dr Justin Turner, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic |
| 1450-1520 | AFTERNOON TEA |
| 1520-1550 | Canva “Nuts and Bolts – Developing Skills” Presentation Keren Moskal, Clinical Librarian and Education Lead, Library, Monash Health, Melbourne, Vic Wendy Ewing, Deputy Director of Pharmacy - Quality, Monash Health, Melbourne, Vic |
| 1550-1620 | Canva “Putting it into Practice “ Workshop Keren Moskal, Clinical Librarian and Education Lead, Library, Monash Health, Melbourne, Vic |
| 1620-1650 | Less screen time - more face time "the art of the executive nudge" Presentation Duncan McKenzie, Director, Pharmacy Programs, Department of Health Tasmania, Tas |
| 1650-1700 | Debrief and Wrap Up Presentation Wendy Ewing, Deputy Director of Pharmacy, Quality, Monash Health, Melbourne, Vic Claire Fitzgerald, Head of Quality and Medication Safety, Slade Pharmacy Quality and Medication Safety Unit Linda Graudins, Senior Pharmacist Medication Safety Program, Alfred Health, Melbourne, Vic Toni Howell, Senior Pharmacist (Medication Safety and Strategy), St Vincent’s Hospital Melbourne, Melbourne, Vic Nam-Anh Nguyen, Medicines Management Pharmacist, WA Country Health Service, WA Lisa Robertson, SW Pharmacy Manager, Safe Medication Practice Unit, Tasmania, Tas |
Registration information
Registration includes afternoon tea.
| Registration category | Early bird | Standard |
|---|---|---|
| AdPha member | $195 | $230 |
| Non-member | $225 | $260 |
Accreditation
This activity has been accredited for 3.33 hours of Group-1 CPD (or 3.33 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number for your reference is S2025/76.
Led by the AdPha Haematology and Oncology Leadership Committee
Time: 1330-1700 AEDT
Room: 218
Preliminary program
| Time (AEDT) | Topic & presenters |
| 1330-1430 | Introduction to Personalised Medicine: An Oncology Pharmacist's Perspective Alison Khor, Cancer Services Pharmacist, St Vincent's Hospital Melbourne, Melbourne, Vic Learning objectives: • Explain the principles and significance of personalised medicine in oncology/haematology in modern day practice • Discuss recent advances and emerging therapies in targeted treatments and immunotherapy, as well as theranostics. • Describe the role of pharmacists in integrating personalised treatment approaches within multidisciplinary cancer care |
| 1430-1515 | Pharmacogenomics in cancer Sarah Glewis, Senior Pharmacogenomics Pharmacist and PhD Candidate, Peter MacCallum Cancer Centre, Melbourne, Vic Learning Objectives • Describe the foundational principles of pharmacogenomics (PGx), and the evidence for PGx testing into routine oncology clinical care. • Explain how PGx is used to optimise medication prescribing. • Identify available PGx resources and demonstrate how to effectively use them. • Identify barriers to PGx implementation in routine clinical practice and implementation of PGx program at PeterMac. • Apply PGx knowledge in practice using a patient case study to demonstrate its implementation in routine clinical care |
| 1515-1545 | AFTERNOON TEA |
| 1545-1630 | From breakthrough to burden: Complications of CAR-T therapy David Seymour, Senior Pharmacist Palliative Care, Alfred Health, Melbourne, Vic Learning Objectives: • Discuss CAR-T therapy and complications associated with this treatment option • Understand the importance of managing these complications • Recommend treatment options to manage these complications |
| 1630-1700 | The Use of CAMs in Cancer Therapies: Ivermectin and Fenbendazole Alison Nguyen, Haematology Pharmacist, Monash Health, Melbourne, Vic Learning Objectives: • Discuss the role of Complementary and Alternative Medicine (CAM) in cancer therapy • List common examples of CAM interactions with chemotherapy regimens • Describe the principles of how to approach CAM related requests and queries • Summarise the role and current evidence of antiparasitics such as ivermectin and fenbendazole in cancer therapy • Identify resources for managing CAM interactions and safety enquiries |
Registration information
Registration includes afternoon tea.
| Registration category | Early bird | Standard |
|---|---|---|
| AdPha member | $210 | $245 |
| Non-member | $240 | $275 |
Accreditation
This activity has been accredited for 0.75 hours of Group-1 CPD and 2.25 hours of Group-2 CPD for a total of 5.25 CPD credits, suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number for your reference is S2025/66.
Collaboratively led by the AdPha Cardiology and Research Leadership Committees
Time: 1320-1700 AEDT
Room: 216
Session leads
Preliminary program
| Time (AEDT) | Topic & presenters |
| 1320-1330 | Introducing the new ACS guidelines published April 2025 Kate Ziser, Clinical Educator Pharmacist, Princess Alexandra Hospital, Brisbane, Qld Learning Objectives: • Overview the main changes relevant to clinical pharmacists from the updated ACS guidelines. |
| 1330-1350 | What are the major changes in practice Kate Ziser, Clinical Educator Pharmacist, Princess Alexandra Hospital, Brisbane, Qld Learning Objectives: • Overview the main changes relevant to clinical pharmacists from the updated ACS guidelines. |
| 1350-1400 | Understand how these changes were decided by the authors Adam Livori, Lead Cardiology Pharmacist, Grampians Health, Ballarat, Vic; PhD, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic Learning Objectives: • Describe the process of guideline writing, systematic review, consensus agreement, and language use in phrasing recommendations. |
| 1400-1410 | Understand the hierarchy of evidence synthesis Adam Livori, Lead Cardiology Pharmacist, Grampians Health, Ballarat, Vic; PhD, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic Learning Objectives: • Explain the balance between experimental design and real-world evidence in guiding decisions and pragmatic care. |
| 1410-1430 | Understand the difference between randomised control results and adjusted results from observational studies Adam Livori, Lead Cardiology Pharmacist, Grampians Health, Ballarat, Vic; PhD, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic Learning Objectives: • Explain the difference between randomised control results and adjusted results from observational studies |
| 1430-1515 | Application of knowledge – Decide if a patient requires colchicine during an acute coronary syndrome Small group session Learning Objectives: • Explain the difference between randomised control results and adjusted results from observational studies |
| 1515-1525 | Case wrap up |
| 1525-1545 | AFTERNOON TEA |
| 1545-1605 | Understand the steps involved interpreting a meta-analysis Kate Ziser, Clinical Educator Pharmacist, Princess Alexandra Hospital, Brisbane, Qld Learning Objectives: • Describe the steps involved interpreting a meta-analysis |
| 1605-1650 | Application of knowledge – Determine initial DAPT plan for a given patient Small group session Learning Objectives: • Describe the steps involved interpreting a meta-analysis |
| 1650-1700 | Case wrap up |
Overall Learning Objectives
Registration information
Registration includes afternoon tea.
| Registration category | Early bird | Standard |
|---|---|---|
| AdPha member | $195 | $230 |
| Non-member | $225 | $260 |
Accreditation
This activity has been accredited for 3.5 hours of Group-2 CPD (or 7 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number for your reference is S2025/67.
Collaboratively led by the AdPha Critical Care, Emergency Medicine, and Infectious Diseases Leadership Committees
Time: 1330-1700 AEDT
Room: 217
Preliminary program
| Time (AEDT) | Topic & presenters |
| 1330-1340 | Introduction to sepsis Rachael Leng, Sepsis/AMS Pharmacist, Alfred Health, Melbourne, Vic |
| 1340-1345 | Emergency department: Patient perspective video Fiona Doukas, Senior Project Officer, Australian Commission on Safety and Quality in Health Care, Sydney, NSW |
| 1345-1415 | Emergency department: Interactive case study Dr Cristina Roman, Lead Pharmacist Emergency Medicine, Alfred Health; Chair, AdPha Emergency Medicine Leadership Committee, Melbourne, Vic |
| 1415-1430 | ICU: Translating evidence into practice Namita Warrior, Senior ICU Pharmacist - Quality, Safety & Improvement, Western Health, Melbourne, Vic |
| 1430-1500 | ICU: Interactive case study Namita Warrior, Senior ICU Pharmacist - Quality, Safety & Improvement, Western Health, Melbourne, Vic |
| 1500-1530 | AFTERNOON TEA |
| 1530-1550 | Ward: Mock sepsis call drill Rachael Leng, Sepsis/AMS Pharmacist, Alfred Health, Melbourne, Vic; Dr Cristina Roman, Lead Pharmacist Emergency Medicine, Alfred Health; Chair, AdPha Emergency Medicine Leadership Committee, Melbourne, Vic |
| 1550-1615 | Ward: Interactive case study Rachael Leng, Sepsis/AMS Pharmacist, Alfred Health, Melbourne, Vic |
| 1615-1645 | Transition to home: Interactive case study Fiona Doukas, Senior Project Officer, Australian Commission on Safety and Quality in Health Care, Sydney, NSW |
| 1645-1700 | Conclusion |
Learning objectives
Registration information
Registration includes afternoon tea.
| Registration category | Early bird | Standard |
|---|---|---|
| AdPha member | $210 | $245 |
| Non-member | $240 | $275 |
Accreditation
This activity has been accredited for 1 hour of Group-1 CPD and 2 hours of Group-2 CPD for a total of 5 CPD credits, suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number for your reference is S2025/69.
